QUALIGEN THERAPEUTICS INC - COM NEW (QLGN)

CUSIP: 74754R202

Q2 2023 13F Holders as of 30 Jun 2023

Share change
+21,090
SEC-reported price per share
$0.91
Number of holders
15
Value change
+$3,206,731
Number of buys
6
Number of sells
2

Security key

74754R202

Report period

Q2 2023

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of QLGN - QUALIGEN THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F 3/4/5 Highest disclosed value: $23,905 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $23.9K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $23.9K
GEODE CAPITAL MANAGEMENT, LLC $20.7K
UBS Group AG $10.4K
STATE STREET CORP $10.1K
HighMark Wealth Management LLC $7.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$23,905
25,840 shares
— 31 Mar 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$20,658
22,329 shares
— 31 Mar 2023
UBS Group AG
13F
Company
13F
—
denominator unverified
$10,431
11,277 shares
— 31 Mar 2023
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$10,112
10,930 shares
— 31 Mar 2023
HighMark Wealth Management LLC
13F
Company
13F
—
denominator unverified
$7,409
8,009 shares
— 31 Mar 2023
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$2,000
1,982 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
102,994
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
11
Q2 2023 holders
15
Holder diff
4
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .